Teva announces launch of generic Zetia in U.S.
Teva Pharmaceutical Industries announced the launch of generic Zetia tablets, 10 mg, in the U.S. Ezetimibe is a prescription medicine used to lower levels of total cholesterol and low-density lipoprotein cholesterol in the blood. Ezetimibe tablets are for patients who cannot control their cholesterol levels by diet and exercise alone. It can be used by itself or with other medicines to treat high cholesterol. Ezetimibe tablets work to reduce the amount of cholesterol the body absorbs. "Despite advances in the treatment of high cholesterol in recent years, many people are still living with active disease and are in need of additional generic therapeutic options," said Dipankar Bhattacharjee, Teva's President and CEO, Global Generic Medicines. "We are excited to add another strong generic to our U.S. portfolio and see potential to build on its success by leveraging our expertise in the cardiovascular area."